A reduced insulin/IGF-1 signaling in experimental animal model protects the mammalian brain from amyloid-β toxic effects, neurodegeneration, and Alzheimer disease [71]. Here, IGF1 is linked to early-onset autosomal dominant Alzheimer disease.